A 2012 Oxford University study, published in The Lancet medical journal, showed that even very low-risk patients benefited from taking cholesterol-lowering statins.
Rory Collins, professor of medicine at Oxford University, worked on the research and said the number of people who could begin taking statins as a result of the new Nice guidance "would be in the the order" of around five million.
He added: "The evidence is very strong that the treatment is cost-effective at these lower levels. Doctors are now in a position to offer statins on this basis."
He said it was up to individual patients to decide whether they wanted to take statins, based on their risk assessment, but Nice's strategy would "reduce the burden on the health service".
The NHS estimates that statins save 7,000 lives a year in the UK.
More top news
Liverpool edged an epic penalty shootout to beat Middlesbrough and progress to the fourth round of the Capital One Cup.
The world famous musical, which has been running on Broadway since 1997, has broken records earning more than £2.8 billion.
There will be wet weather around tonight with rain drifting from north to south which will lead to scattered showers tomorrow morning.